Pregnenolone derivatives for the treatment of Alzheimer's disease: synthesis, and in vitro inhibition of amyloid β_1–42 peptide aggregation, acetylcholinesterase and carbonic anhydrase-II

Abstract

Pregnenolone-based derivatives have been synthesized to inhibit the protofibril formation in order to reduce Aβ1–42 production and prevent its aggregation.